Press Releases Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-12 pm EDT			5-day change	1st Jan Change
0.5151 ^USD	+3.02%		+16.54%	-57.08%

Jun. 20	Critical Path Institute and Centogene N.V. Announces the Signing of A Memorandum of Understanding to Advance Drug Development for Lysosomal Diseases	CI
May. 16	Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development	Jun. 20	GL
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development	Jun. 20	AQ
Centogene N : Minutes of the 2024 Annual General Meeting of Shareholders - Centogene N.V.	May. 31	PU
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	May. 31	GL
Centogene N : KSA RECEIVABLES TRANSFER AGREEMENT - Form 6-K	May. 15	PU
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	May. 15	GL
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	May. 15	GL
Centogene N : Voting Proxy AGM 2024	May. 15	PU
Centogene N : Convening Notice and Agenda (incl. explanatory notes) (AGM 2024)	May. 15	PU
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	May. 14	GL
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	May. 13	AQ
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	May. 10	GL
Centogene N : Form 6-K	May. 02	PU
CENTOGENE Receives Nasdaq Non-Compliance Notice	Apr. 02	GL
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders	Mar. 19	GL
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency	Feb. 29	GL
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing	Feb. 28	GL
CENTOGENE Explores Strategic Alternatives	Feb. 28	GL
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration	Jan. 25	GL
CENTOGENE Receives French Research Tax Credit Accreditation	Jan. 24	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Centogene N.V.

Equities

CNTG

NL0014040206

Press Releases

Filters